ProfileGDS5678 / 1436831_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 64% 62% 63% 63% 63% 65% 65% 63% 63% 63% 63% 62% 66% 63% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.8873364
GSM967853U87-EV human glioblastoma xenograft - Control 23.670962
GSM967854U87-EV human glioblastoma xenograft - Control 33.74363
GSM967855U87-EV human glioblastoma xenograft - Control 43.7289563
GSM967856U87-EV human glioblastoma xenograft - Control 53.70563
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.9752965
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.9553565
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.7941163
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.7524763
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.7714763
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.7661963
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.6495862
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 44.000766
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.7896363